Gallic Acid

Gallic Acid

SCHEMBL29769830

O=C([O-])c1cc(O)c(O)c(O)c1.O=C([O-])c1cc(O)c(O)c(O)c1.O=C([O-])c1cc(O)c(O)c(O)c1.[Ga+3]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ TDP1 Q9NUW8 3/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ FUT7 Q11130 2/20 0.56
▸ CA1 P00915 2/20 0.56
▸ CA2 P00918 2/20 0.56
▸ CA12 O43570 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ CA3 P07451 1/20 0.56
▸ SELL P14151 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ SELP P16109 1/20 0.56
▸ FUT4 P22083 1/20 0.56
▸ CA4 P22748 1/20 0.56
▸ CA6 P23280 1/20 0.56
▸ DPP4 P27487 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ CA5A P35218 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid SCHEMBL28311724 0.97 KDM4E (0.54) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL28654164 0.97 KDM4E (0.59) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL15529595 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL1738962 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL338355 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL9403690 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL9185403 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL21273262 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL21273260 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT
Gallic Acid SCHEMBL2589994 0.95 KDM4E (0.56) KDM4ELMNATDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114699372-B Application of nano-drug targeting iron death in treating acute kidney injury 浙江大学医学院附属第四医院 2023-11-24 — — CN claimed
CN-114699372-A Application of targeted iron death nano-drug in treatment of acute kidney injury 浙江大学医学院附属第四医院 2022-07-05 — — CN claimed
WO-2024258867-A1 SYSTEM AND METHOD FOR PRESERVING ALGAE Macro Oceans Inc. (US) 2024-12-19 — — WO disclosed
US-20240409878-A1 SYSTEM AND METHOD FOR PRESERVING ALGAE Macro Oceans Inc. (US) 2024-12-12 — — US disclosed
CN-114699372-B Application of nano-drug targeting iron death in treating acute kidney injury 浙江大学医学院附属第四医院 2023-11-24 — — CN disclosed
CN-114699372-B Application of nano-drug targeting iron death in treating acute kidney injury 浙江大学医学院附属第四医院 2023-11-24 — — CN disclosed
CN-114699372-A Application of targeted iron death nano-drug in treatment of acute kidney injury 浙江大学医学院附属第四医院 2022-07-05 — — CN disclosed
CN-114699372-A Application of targeted iron death nano-drug in treatment of acute kidney injury 浙江大学医学院附属第四医院 2022-07-05 — — CN disclosed
Send feedback